![](/img/cover-not-exists.png)
Hyperimmune IVIG may be advantageous in comparison to intravenous ganciclovir as a preemptive antiviral therapy in CMV-positive heart transplant recipients
C.D Thomas, R Radovancevic, E.L Ford, B Radovancevic, O.H FrazierVolume:
21
Year:
2002
Language:
english
DOI:
10.1016/s1053-2498(01)00536-8
File:
PDF, 46 KB
english, 2002